Arkolith/Insider Trading/CGEM/Form 4

Sumer Jacquelyn L

Chief Legal OfficerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Dec 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$40K
Net Open-Market Flow
-$40K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2024Sell(S)3K$11.41$40K91K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-139123) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML